Stock listing

Veru Inc.

Selected listing: FMW0 · MUN · EUR · DE

Veru Inc. (Munich:FMW0), Health Technology. Latest release Sep 8, 2026: Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent…

FMW0:MUNEURDEUpdated October 2, 2026

Ticker: Munich:FMW0
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Munich
Currency: EUR

Latest news from Veru Inc.

Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial

September 8, 2026

Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference

September 2, 2026

Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress

August 10, 2026

Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss

August 4, 2026

Veru to Report Fiscal 2026 Third Quarter Financial Results on August 10th

August 3, 2026

All Veru Inc. news →

Events

Replays

Veru Inc. (VERU) Q3 2026 Earnings Call
Mon, Aug 10, 2026 · 08:00 AM ET
Watch
Veru Inc. (VERU) Q2 2026 Earnings Call
Wed, May 13, 2026 · 08:00 AM ET
Watch
Veru Inc. (VERU) Q1 2026 Earnings Call
Wed, Feb 04, 2026 · 08:00 AM ET
Watch

Research Veru Inc.

Veru Inc. company profile

View the public company page for Veru Inc. on 6ix.

Veru Inc. news

Read company news and market updates connected to Veru Inc..

Veru Inc. investor events

Find investor webinars, events, and replay context for Veru Inc..